Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
VANGL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
AKIRIN2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PEX3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC284294 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
ZNF45 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GLG1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NDFIP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF337 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRIAP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LGALSL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TYW5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIR4271 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GOSR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM109 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
FGL2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZFHX3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GOSR2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on